Global Health Economics Summit July 25-26, 2016 Berlin, Germany

Johannes Bircher has completed his professional formation at the University of Zürich, and his postgraduate education at the Mayo Clinic and the University of Zürich. Then he worked at the Department of Clinical Pharmacology of the University of Bern, at the Black Lion Hospital in Addis Ababa and at the University of Gottingen before he became dean of the Faculty of Medicine at the University of Witten/Herdecke. Now he is retired. He published 253 papers partly in high ranking scientific journals, and seven books.

1969 Graduation in Medicine in Hamburg, Germany. 2002 Master of Medical Education in Bern. 1987-2009 Professor of Medicine and Director of Clinical Departments at Thomas Jefferson University, Philadelphia, USA and Friedrich-Alexander-University Erlangen-Nürnberg. 2009-2011 Past Dean of the Faculty of Health, University of Witten/Herdecke. 2011-2013 Past Founding Dean of the Faculty of Medicine and Health Sciences, University of Oldenburg. He is currently Founding Adviser for a Center of Integrative Medicine and Health, Bamberg. 748 published papers (SCI-listed).

Richard M. Scheffler is a Distinguished Professor of Health Economics and Public Policy at the School of Public Health and the Goldman School of Public Policy at the University of California, Berkeley. He also holds the Chair in Healthcare Markets & Consumer Welfare endowed by the Office of the Attorney General for the State of California. Professor Scheffler is the director of The Nicholas C. Petris Center on Health Care Markets and Consumer Welfare. He has been a Rockefeller and a Fulbright Scholar, and served as the President of the International Health Economists Association 4th Congress in 2004. Professor Scheffler has published about 200 papers and edited and written twelve books, including his most recent book, The ADHD Explosion: Myths, Medication, Money and Today's Push for Performance with Stephen Hinshaw, published by Oxford Press in March 2014, which was supported by a Robert Wood Johnson Investigator Award. He has conducted a recent review on Pay For Performance in Health for the World Health Organization and the OECD. He was awarded the Fulbright Scholarship at Pontifica Universidad Católica de Chile in in Santiago, Chile as well as the Chair of Excellence Award at the Carlos III University of Madrid in Madrid, Spain in 2012 through 2013. He was just awarded the Gold Medal from Charles University in Prague, Czech Republic for his continued support of international scientific and educational collaboration in 2015.

Extremely broad background in research, including many fields of medicine (wound care, evidence-based medicine, cost-effectiveness studies, epidemiology, ophthalmology, the study of pain, genetics, and burns, biochemistry, chemistry, and materials science), as well as decades of writing, editing, and publishing in these fields. Extensive experience in biostatistics, cost-effectiveness modeling, EBM study assessment (systematic reviews and meta-analysis) and clinical practice guideline creation, and designing clinical trial protocols. Experienced consultant with CMS and FDA. Extensive nutritional research and analysis. MEMBERSHIPS- APWCA (American Professional Wound Care Association) AAWC (Association for the Advancement of Wound Care) ACHM (American College of Hyperbaric Medicine) PAAO (Pan American Association for Ophthalmology

Dr. Sudip Chattopadhyay is the professor and past chairman of the Economics Department at San Francisco State University (SFSU). He obtained his Ph. D. in Economics in 1997 from University of Illinois at Urbana-Champaign. He has been on the SFSU Economics faculty since 1999. His research interest is in applying economic theories and models for economic evaluation of public policies, specifically in the areas of health and the environment. He has published in numerous peer-reviewed journals. His works have been extensively cited and some of them have been reprinted in special volumes for their enduring quality. Currently, Dr. Chattopadhyay is serving as an ORISE Fellow at the federal office of Health Resources and Services Administration (HRSA) to establish a research agenda focusing on healthcare workforce.

Martin Kowarsch heads the working group ‘Scientific Assessments, Ethics, and Public Policy’ (SEP) at the Mercator Research Institute on Global Commons and Climate Change (MCC) Berlin. SEP does research on integrated scientific assessment-making in the context of (environmental) public policy processes, and focuses in particular on the appropriate treatment of, and ethical reflection on, normative issues and multiple stakes therein. Kowarsch is coordinator of a research initiative by MCC jointly with the United Nations Environment Programme (UNEP) on ‘the Future of Global Environmental Assessment Making’.

• Design of integrated scientific assessments, particularly environmental assessments • Normative and theoretical models of scientific expertise in public policy • Ethical issues at the science-policy interface, and the co-production of knowledge • Deweyan pragmatist ethics of land use policy and the global commons

Dr Jan Baekelandt qualified as a Medical Doctor (1999) and specialist in Gynaecology and Obstetrics (2004) at the Catholic University of Leuven, Belgium. He subspecialized as gynaecological oncologist (2004-2006) in Pretoria (South Africa) and Köln (Germany). He currently consults at Imelda Hospital (Bonheiden, Belgium), specializing in gynaecological oncology, and robotic and endoscopic surgery. He is a pioneer in the emerging field of Natural Orifice Surgery and has published multiple papers on transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES). He was first to introduce transvaginal robotic surgery

Umberto Petruccelli is Professor at the School of Engineering of the University of Basilicata (Potenza - Italy) since 2001, formerly Assistant Professor (1986-2001), where he holds the courses of "Transport techniques and economics" and "Urban and metropolitan transport". He worked, as well as research manager, in inter-university national and international research programs and also in research agreements with public institutions aimed at the study of relevant transportation issues. He published many scientific papers on the Italian and international literature. His recent research activity has focused on mobility analysis and planning, with special regard to the quality and the standard cost of transit services, the impact and cost of transport externalities, the management of the urban road system and the safety of the transport system ordinary and disable users.

Dr. Carl Asche is the Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria, where he is a Research Professor both in the Departments of Medicine (Peoria) and Pharmacy Systems, Outcomes & Policy (Chicago). He is also a research affiliate with the University of Victoria Centre on Aging. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of being the author or co-author of over 75 papers appearing in the medical and economic literature. He is the editor of the forthcoming book entitled, “Applying Comparative Effectiveness Data to Medical Decision Making: A Practical Guide” (Adis, 2015). He has presented his research at seminars and conferences both nationally and internationally. He has served on numerous national and international health economics focused editorial, grant review, advisory boards and committees. Dr. Asche’s research is funded by a variety of state/federal agencies and health system providers.

-

Katarzyna is a Market Access Director for Region East at Lundbeck. In the past, she worked for AstraZeneca, Bristol Myers Squibb as well as BiogenIdec leading Market Access teams in CEE Region. In total, she has been working for pharmaceutical industry for more than ten years now. The last six years she devoted mainly to Market Access for CEE Region. Her office is located in Finland. In the past she was based in Sweden and Switzerland. She holds a PhD degree in health economics and is an author of the number of publications in the field of health technology assessment and pharmacoeconomics. Katarzyna Kolasa has been invited to review manuscripts for Health Policy, Value in Health, Expert Review of Pharmacoeconomics & Outcomes Research and International Journal for Equity in Health. Her extensive knowledge in the field of health economics was acquired at University of York, University of Lund and University of Bergen as well as during International Doctoral Courses in Health Economics and Policy organized by the Swiss School of Public Health. Katarzyna Kolasa is DIA tutor for HTA courses, teacher at MBA in health program at Lazarski University, HTA training at Business School of Technical University in Warsaw and Adjunct at Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. In addition to her role as a University teacher, she lead Equity study as a part of InterQuality project organized by Warsaw Medical University, funded under the European Union\'s Seventh Framework Programme. She worked for World Bank regarding the hospital management project as well. Her practical skills in the field of health economics were developed during her six years employment contract at the Kalmar County Council in Sweden where she was responsible for a number of public health research programmes.

Dr. K.P. Mishra is a Vice Chancellor of Nehru Gram Bharati University (Deemed-to-be University) , Allahabad in Jan. 2010-2014. He is Chairman and Director for Research Center, Nehru Gram Bharati University, Allahabad in Jan. 2010-2014. Founder President of Society of Radiation Researchers of India, 2014 onwards. President of Section of Biochem.Biopys& Mole.Biology( now New Biology). President of Indian Society for Radiation Biology, 2003-2005, 2005-2008. President of Foundation for Education and Research ( India)-2014 onwards. Vice President of Asian Association of Radiation Research, 2005-2009 , 2009-2013, 2013-17. Vice President of Bioelectrochemical Society of India, 1996-2001. Executive Council Member for Indian Biophysical Society, 1999-2001. He is honoured with CCI Technology in Education Excellence Award 2014, Heramba Mishra Award of Excellence, 2011, Distinguished Fellowship Award of Nagoya University, Japan, 2011, Honored as Icon of Allahabad by Indian Management Association, Allahabad. Chapter, Alld.2010, Honored with conferment of Fellowship of Intl Academy of Physical Sciences, 2010, He was Head, Radiation Biology and Health Sciences Division of Bhabha Atomic Research Center, Mumbai

Dr. Teckle is a Health Economist at the Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency and an Assistant Professor in the School of Population and Public Health at the University of British Columbia. Previously he held positions at Health Economics Research Unit, University of Aberdeen UK. Whilst at the University of Aberdeen, Dr. Teckle was part of a research team that was commissioned by the Scottish Executive Health Department in 2005 to improve and refine the Arbuthnott Resources Allocation Formula used in Scotland. Since he joined the ARCC in 2006, Dr. Teckle has been working as a co-investigator in three projects: “Health-related quality of life in cancer patients”; “Long-term income and employment outcomes in cancer-survivors”, and “Phase-specific and lifetime costs of cancer in British Columbia and Ontario”. The objective of the first project is to evaluate the reliability and validity of cancer-specific measures of health related-quality of life in patients with cancer in BC. The objective of the second project is to estimate the effect of socio-demographic and clinical factors on cancer survivors’ income, and their ability to participate in the labor force using cross-sectional and longitudinal models; and the objective of the last project is to estimate costs for eighteen most common types of cancer in British Columbia. Over the course of his academic career, Dr. Teckle has published a number of scientific papers.

-

Professor Khalid’s is a clinical cardiologist by training, Professor Khalid previously served as the Dean of Universiti Teknologi MARA’s Faculty of Medicine. Under his stewardship, the faculty recorded tremendous growth and established itself as one of the foremost medical faculties in the nation. Prior to that, Professor Khalid played a number of key roles – including serving as Dean – in a career spanning two decades at Universiti Kebangsaan Malaysia. He also served as a consultant cardiologist at both universities where he was instrumental in developing the Heart Centres at these universities. Professor Khalid began his medical career as a student at The University of Melbourne, Australia. He was then trained in Cardiology at the University of Newcastle-upon-Tyne, UK. On returning to Malaysia, he built a strong career in academia, bolstered by national and international recognition of his contributions. He is a firm advocate of research and development and his findings are frequently published in high-impact international journals. His papers are cited and referred to by many of his peers, adding credence to his standing as an academic. What Professor Khalid brings to UCSI further enhances the University’s strong links with the industry and its vibrant student life. The latest addition to Professor Khalid’s ever expanding list of accolades and awards is a Doctor of Medical Sciences (honoris causa) conferred by his alma mater, The University of Melbourne, Australia in October 2014. The citation for the honorary doctorate by the Melbourne University’s Council identifies him as a person of distinguished eminence in medical science, research and effective medical education. His international outlook was best demonstrated in his development and forging of strategic partnerships between UCSI and world leading universities, culminating in UCSI’s proudest moment when our top Year 2 medical student was selected for an intercalated research year at Harvard University in the USA.